Device-Based Treatments for Substance Use Disorders (UG3/UH3)

The purpose of this grant is to accelerate the development of devices to treat Substance Use Disorders (SUDs). Applications may focus on the pre-clinical and/or clinical development and testing of new devices or existing devices approved for other indications. Applications may evaluate the mechanism of action of a device.

Funding: UG3 $500,000 per year; UH3 no fixed limit 

Duration: UG3 2 year; UH3 3 years 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 15.11.20, 10.7.21, 14.11.21, 10.7.22, 14.11.22, 10.7.23

Full proposal due date:  15.12.20, 10.8.21, 14.12.21, 10.8.22, 14.12.22, 10.8.23